Vous possédez un compte ?
Connectez-vous pour payer plus vite.
Chargement en cours...
mai 2024
juin 2024
Découvre pourquoi tu devrais commencer ton aventure probiotiques avec Bio-K+.
Nos formules scientifiquement étudiées sont conçues pour soutenir votre parcours unique de bien-être
Probiotics for the vaginal microbiome are not all equivalent, and the research clearly reflects that. The vaginal microbiome is a community of microorganisms, primarily Lactobacillus species, that play a central role in maintaining vaginal microbiome health. When this Lactobacillus-dominant state is disrupted, the result is a shift in the vaginal environment that affects healthy vaginal flora. Probiotics for vaginal health are most relevant when they are built around strains with documented urogenital origins and a substantial published evidence base.
Bio-K+ Women's Health Capsules contain Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™, the world's most documented probiotics combination for women's urogenital health, backed by more than 20 years of research, 60+ scientific publications, and more than 25 clinical trials. These strains have been tested across diverse women populations, including pregnant women and women with HIV, without any serious adverse events reported.
The vaginal microbiome can be disrupted by antibiotics, hormonal shifts during the menstrual cycle, perimenopause, and pregnancy, and certain hygiene practices. These disruptions reduce the Lactobacillus populations that support vaginal flora health. Consistent, daily probiotic support is the context in which GR-1™ and RC-14™ has been most extensively studied.
Restoring vaginal flora after disruption and maintaining a healthy vaginal flora state over time are the two Health Canada-approved claims that Bio-K+ Women's Health Capsules carry: "Helps restore and maintain healthy vaginal flora" and "Reduces yeasts and bacteria on vaginal surfaces to maintain feminine health." Supporting vaginal microbiome health as part of a daily wellness routine is the maintenance framing this evidence base supports.
Understanding how oral probiotics for vaginal health work requires understanding the gut-vagina axis. This is the biological connection through which specific oral probiotic strains, after surviving gut transit, can support the vaginal tract. GR-1™ was isolated from the distal urethra of a healthy woman in 1980; RC-14™ was isolated from the vagina of a healthy woman in 1985.
Bio-K+ Women's Health Capsules deliver 2 billion CFU of GR-1™ and RC-14™ per capsule, guaranteed until the expiry date, in a vegan, gluten-free, non-GMO oral capsule that requires no refrigeration.
The vaginal microbiome is the community of microorganisms naturally present in the vaginal tract. In a healthy state, it is primarily composed of Lactobacillus species that produce lactic acid, helping maintain the vaginal environment. This Lactobacillus-dominant state is associated with vaginal flora health and overall comfort. When the composition of this community shifts, a state of dysbiosis can occur. Understanding what supports and what disrupts the vaginal microbiome is the starting point for making informed decisions about vaginal health.
Antibiotics are among the most well-documented disruptors of vaginal microbiome health because they can affect both beneficial and harmful bacteria. Hormonal changes, including menstrual cycle fluctuations, perimenopause, and pregnancy, can also shift the Lactobacillus-dominant state of the vaginal tract. Certain hygiene practices, such as douching, are also associated with disruption. Recognizing these disruption factors helps explain why consistent, daily support for vaginal flora health is relevant to a broader range of women than those experiencing acute symptoms.
The gut-vagina axis is the biological connection through which specific oral probiotic strains can support vaginal health after surviving transit through the digestive system. Not all probiotic strains have this capacity; it is strain-specific. Lacticaseibacillus rhamnosus GR-1™ was isolated from the distal urethra of a healthy woman in 1980, and Limosilactobacillus reuteri RC-14™ from the vagina of a healthy woman in 1985; their origins and their research base are both oriented toward the female urogenital environment.
Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™ are the world's most documented probiotics combination for women's urogenital health. Their research history spans more than 20 years, covering 60+ scientific publications and more than 25 clinical trials on their health benefits, safety, and mechanism of action. Studies have included pregnant women and women with HIV, without any serious adverse events reported. There are other products on the market with these 2 strains; they are not exclusive to Bio-K+.
Bio-K+ Women's Health Capsules are for adults and adolescents aged 12 and older. Take one oral capsule 1 to 2 times per day, or as recommended by a healthcare practitioner. The product delivers 2 billion CFU of Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™ per capsule, guaranteed until the expiry date. No refrigeration is required. The capsules are gluten-free, vegan, non-GMO, and titanium dioxide-free. Consistent daily use is the approach studied across the clinical research on these strains.
Suis @biokplus et tague-nous pour être mentionné.e.
